Department of Laboratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
State Key Laboratory of Respiratory Disease, Institute of Integration of Traditional and Western Medicine, Guangzhou Medical University, Guangzhou, China.
J Med Virol. 2022 Jun;94(6):2568-2577. doi: 10.1002/jmv.27642. Epub 2022 Feb 21.
To understand the clinical characteristics of and analyze viral genes in patients with severe pneumonia due to [H1N1]pdm09 influenza virus in Guangzhou, 2019. The clinical data of 120 inpatients with laboratory-confirmed influenza A [H1N1]pdm09 virus from January to March 2019 were collected and analyzed. The subjects were diagnosed according to the criteria of the "Diagnosis and Treatment Program of Influenza A H1N1 (third Edition 2009)" issued by the Ministry of Health and were divided into severe and nonsevere groups. Serum samples during fever were collected for cytokine analysis, and the viral genes were analyzed after the virus cultured in MDCK cells. The data were analyzed by SPSS 16 software, and the results of gene sequencing were analyzed by MEGA 6 software. Among the 120 inpatients, 36 (30%) were severe and 84 (70%) were nonsevere patients. The average age of severe patients was 53.11 ± 19.94 years, the average age of nonsevere patients, at 44.03 ± 24.47 years. There was no significant difference between the two groups (p < 0.05). There were significant differences in the rates of moist rales and dyspnea in critically ill patients (p < 0.05). There were significant differences in the white blood cell count (WBC), lactate dehydrogenase (LDH), creatine kinase (CK), serum creatinine (sCr), procalcitonin (PCT) and C-reactive protein (CRP) in severe patients with type A H1N1. Chest radiologic findings in severe patients showed ground glass shadows or pulmonary solid changes, and the difference was statistically significant for pulmonary fibrosis. Chronic lung disease (52.8%) and cardiovascular disease (27.8%) were independent risk factors for severe disease (p < 0.05). There were significant differences in secondary infections by Staphylococcus aureus (11.1%), pulmonary Aspergillus (22%) and Acinetobacter baumannii (16.7%) in critically ill patients (p < 0.05). Serum IL-8 in critically ill patients was significantly higher than those in nonsevere patients and healthy controls. The origin of virus strains in severe and nonsevere patients was the same, and there was no obvious mutation in the amino acid region of the antigenic site of the HA protein, but compared with the results of gene sequencing in previous years, the mutation sites showed a trend of annual accumulation. In conclusion, there was a high risk of severe pneumonia caused by H1N1 influenza A virus in Guangzhou in spring 2019. Long-term continuous surveillance, prevention and control of the virus should be carried out to predict its epidemiology and distribution.
为了了解 2019 年广州地区由 [H1N1]pdm09 流感病毒引起的重症肺炎患者的临床特征并分析其病毒基因,收集并分析了 2019 年 1 月至 3 月期间确诊为甲型流感 A [H1N1]pdm09 病毒的 120 例住院患者的临床资料。根据卫生部发布的《甲型 H1N1 流感诊疗方案(第三版 2009 年)》的标准进行诊断,并将患者分为重症和非重症两组。采集发热期血清进行细胞因子分析,并在 MDCK 细胞中培养病毒后分析病毒基因。使用 SPSS 16 软件进行数据分析,使用 MEGA 6 软件分析基因测序结果。在 120 例住院患者中,36 例(30%)为重症患者,84 例(70%)为非重症患者。重症患者的平均年龄为 53.11 ± 19.94 岁,非重症患者的平均年龄为 44.03 ± 24.47 岁。两组之间无显著差异(p < 0.05)。重症患者的湿性啰音和呼吸困难发生率存在显著差异(p < 0.05)。重症甲型 H1N1 患者的白细胞计数(WBC)、乳酸脱氢酶(LDH)、肌酸激酶(CK)、血清肌酐(sCr)、降钙素原(PCT)和 C 反应蛋白(CRP)存在显著差异。重症患者的胸部影像学表现为磨玻璃影或肺部实变,肺纤维化差异有统计学意义。慢性肺部疾病(52.8%)和心血管疾病(27.8%)是重症疾病的独立危险因素(p < 0.05)。重症患者的金黄色葡萄球菌(11.1%)、肺曲霉菌(22%)和鲍曼不动杆菌(16.7%)继发感染发生率存在显著差异(p < 0.05)。重症患者的血清 IL-8 明显高于非重症患者和健康对照组。重症和非重症患者的病毒株来源相同,HA 蛋白抗原位点的氨基酸区域没有明显突变,但与前几年的基因测序结果相比,突变位点呈现出逐年积累的趋势。总之,2019 年春季广州地区甲型 H1N1 流感病毒引起重症肺炎的风险较高。应长期持续监测、预防和控制该病毒,以预测其流行病学和分布。